Type
Blood Testing
Biomarkers
11
Duration
50 min
Results
7 days
Comprehensive full-body MRI cancer screening to detect early signs of malignancy across all major organ systems. Advanced imaging technology for early cancer detection as part of preventive health strategy.
Whole Body Cancer Screening combines zero-radiation MRI with ultra-low-dose CT chest to capture detailed images from brain to pelvis, detecting early-stage cancers, non-cancerous growths, and structural abnormalities across every major organ system. The MRI component scans brain, spine (cervical, thoracic, lumbar), thyroid, pancreas, spleen, kidneys, adrenal glands, liver, gallbladder, bladder, and other abdominal organs without any radiation exposure. The CT chest component uses ultra-low-dose radiation to image the lungs — tissue that MRI cannot assess effectively. Together they provide coverage that no single imaging modality can achieve alone. The scan takes approximately 50 minutes: 40-50 minutes in the MRI (non-invasive, open at both ends) plus 5-10 minutes for the CT chest with a brief breath-hold. No contrast agents are typically required. Results are reviewed by a specialist radiologist and then explained by an Everlab doctor via video consultation. You receive an interactive digital report with an imaging explorer in the Everlab app, allowing you to view your own scans. If anything concerning is found, Everlab coordinates specialist referrals and follow-up imaging. This screening is not suitable for people under 18, those in active cancer treatment, pregnant women, or those with non-MRI-safe metal implants. It is designed for preventive screening — not for investigating acute symptoms, which should be assessed by a GP first.
Key Details
- Coverage
- Brain to pelvis
- Duration
- ~50 minutes
- Radiation
- Zero (MRI) + ultra-low (CT)
- Results
- 7 business days
Who Is This For?
Preventive cancer screening, those with family history of cancer, anyone wanting peace of mind through comprehensive imaging, health optimisers wanting a full structural baseline
What's Included
Preparation Required
Wear comfortable clothing without metal zippers, buttons, or underwire. Remove all jewellery and piercings. Inform staff of any implants or metal in your body.
Panel Categories
Biomarkers Tested
11A biomarker associated with some breast cancers; used to monitor treatment response in patients with metastatic breast cancer.
A biomarker commonly used in the diagnosis and management of pancreatic and gastrointestinal cancers. Elevated levels can also be found in other conditions such as liver disease.
Tumor marker; elevated levels may indicate certain cancers, particularly gastrointestinal cancers.
The cortisol awakening response (CAR) is a period of increased cortisol secretory activity initiated by morning awakening and typically peaking between 30 and 45min post awakening
Measures only the unbound PSA in the blood.
Imbalances in gut pH influence short-chain fatty acid production and their effects.
- Category
- Diagnostic
- Sample Type
- MRI + ultra-low-dose CT (non-invasive imaging)
- Duration
- 50 min
- Results
- 7 days
